Nicotine
Strategic Sourcing Services Llc
Human Otc Drug
NDC 70677-0031Nicotine is a human otc drug labeled by 'Strategic Sourcing Services Llc'. National Drug Code (NDC) number for Nicotine is 70677-0031. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Nicotine drug includes Nicotine - 14 mg/24h . The currest status of Nicotine drug is Active.
Drug Information:
| Drug NDC: | 70677-0031 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Nicotine |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Nicotine |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Strategic Sourcing Services Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Patch |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | NICOTINE - 14 mg/24h
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TRANSDERMAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | ANDA |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 04 Dec, 2017 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 08 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | ANDA074612 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Strategic Sourcing Services LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 198029
198030
198031
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| NUI: | N0000175706
M0014836
|
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). |
| UNII: | 6M3C89ZY6R
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class EPC: | Cholinergic Nicotinic Agonist [EPC]
|
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. |
| Pharmacologic Class CS: | Nicotine [CS]
|
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. |
| Pharmacologic Class: | Cholinergic Nicotinic Agonist [EPC]
Nicotine [CS]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 70677-0031-1 | 14 POUCH in 1 CARTON (70677-0031-1) / 1 h in 1 POUCH | 04 Dec, 2017 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose stop smoking aid
Product Elements:
Nicotine nicotine nicotine nicotine dimethicone nicotine nicotine nicotine nicotine dimethicone nicotine nicotine nicotine nicotine dimethicone
Indications and Usage:
Uses reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
Warnings:
Warnings if you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. smoking can seriously harm your child. try to stop smoking without using any nicotine replacement medicine. this medicine is believed to be safer than smoking. however, the risks to your child from this medicine are not fully known. ask a doctor before use if you have heart disease, recent heart attack, or irregular heartbeat. nicotine can increase your heart rate. high blood pressure not controlled with medication. nicotine can increase your blood pressure. an allergy to adhesive tape or skin problems because you are more likely to get rashes. ask a doctor or pharmacist before use if you are using a non-nicotine stop smoking drug taking a prescription medicine for depression or asthma. your prescription dose may need to be adjusted. when using this product do not smoke even when not wearing the patch. the nicotine in your skin will still be entering your bloodstream for s
Read more...everal hours after you take off the patch. if you have vivid dreams or other sleep disturbances, remove this patch at bedtime stop use and ask a doctor if skin redness caused by the patch does not go away after four days, or your skin swells, or you get a rash irregular heartbeat or palpitations occur you get symptoms of nicotine overdose, such as nausea, vomiting, dizziness, weakness, and rapid heartbeat keep out of reach of children and pets used patches have enough nicotine to poison children and pets. if swallowed, get medical help or contact a poison control center right away. save pouch to use for patch disposal. dispose of used patch by folding sticky ends together and putting in pouch.
When Using:
When using this product do not smoke even when not wearing the patch. the nicotine in your skin will still be entering your bloodstream for several hours after you take off the patch. if you have vivid dreams or other sleep disturbances, remove this patch at bedtime
Dosage and Administration:
Directions if you are under 18 years of age, ask a doctor before use before using this product, read the enclosed self-help guide for complete directions and other information begin using the patch on your quit day if you smoke more than 10 cigarettes per day , use the following schedule below: weeks 1 thru 4 weeks 5 and 6 weeks 7 and 8 step 1 step 2 step 3 use one 21 mg patch/day use one 14 mg patch/day use one 7 mg patch/day if you smoke 10 or less cigarettes per day, start with step 2 for 6 weeks, then step 3 for 2 weeks apply one new patch every 24 hours on skin that is dry, clean, and hairless remove backing from patch and immediately press onto skin. hold for 10 seconds. wash hands after applying or removing patch. save pouch to use for patch disposal. dispose of used patch by folding sticky ends together and putting in pouch. the used patch should be removed and a new one applied to a different skin site at the same time each day if you have vivid dreams, you may remove the patc
Read more...h at bedtime and apply a new one in the morning do not wear more than one patch at a time do not cut patch in half or into smaller pieces do not leave patch on for more than 24 hours because it may irritate your skin and loses strength after 24 hours it is important to complete treatment. if you feel you need to use the patch for a longer period to keep from smoking, talk to your health care provider.
Stop Use:
Stop use and ask a doctor if skin redness caused by the patch does not go away after four days, or your skin swells, or you get a rash irregular heartbeat or palpitations occur you get symptoms of nicotine overdose, such as nausea, vomiting, dizziness, weakness, and rapid heartbeat
Package Label Principal Display Panel:
Principal display panel - step one 21 mg carton principal display panel - step 1 â 21 mg carton label mckesson sunmark ® ndc 70677-0032-1 compare to the active ingredient in habitrol ®* clear nicotine transdermal system 21 mg delivered over 24 hours stop smoking aid 21 mg includes behavior support program with self-help guide step one if you smoke more than 10 cigarettes per day: start with step 1 if you smoke 10 or less cigarettes per day: start with step 2 14 patches *habitrol® is a registered trademark of novartis consumer health, inc. nicotine-transdermal-system-one-carton.jpg
Principal display panel - step two 14 mg carton principal display panel - step 2 â 14 mg carton label mckesson sunmark ® ndc 70677-0031-1 compare to the active ingredient in habitrol ®* clear nicotine transdermal system 14 mg delivered over 24 hours stop smoking aid 14 mg includes behavior support program with self-help guide step one if you smoke more than 10 cigarettes per day: start with step 1 if you smoke 10 or less cigarettes per day: start with step 2 14 patches *habitrol® is a registered trademark of novartis consumer health, inc. nicotine-transdermal-system-two-carton.jpg
Principal display panel - step three 7 mg carton principal display panel - step 3 â 7 mg carton label mckesson sunmark ® ndc 70677-0030-1 compare to the active ingredient in habitrol ®* clear nicotine transdermal system 7 mg delivered over 24 hours stop smoking aid 7 mg includes behavior support program with self-help guide step one if you smoke more than 10 cigarettes per day: start with step 1 if you smoke 10 or less cigarettes per day: start with step 2 14 patches *habitrol® is a registered trademark of novartis consumer health, inc. nicotine-transdermal-system-three-carton.jpg